This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 1995 Aug;26(2):547-52.

doi: 10.1016/0735-1097(95)80035-f.

Physician use of beta-adrenergic blocking therapy: a changing perspective

H L Kennedy, R S Rosenson

PMID: 7608462
DOI: 10.1016/0735-1097(95)80035-f

Free article

Editorial

Physician use of beta-adrenergic blocking therapy: a changing perspective

H L Kennedy et al. J Am Coll Cardiol. 1995 Aug.

Free article

. 1995 Aug;26(2):547-52.

doi: 10.1016/0735-1097(95)80035-f.

Authors

H L Kennedy, R S Rosenson

PMID: 7608462
DOI: 10.1016/0735-1097(95)80035-f

No abstract available

PubMed Disclaimer

Similar articles

Physician characteristics and the initiation of beta-adrenergic blocking agent therapy after acute myocardial infarction in a managed care population.
Fehrenbach SN, Budnitz DS, Gazmararian JA, Krumholz HM. Fehrenbach SN, et al. Am J Manag Care. 2001 Jul;7(7):717-23. Am J Manag Care. 2001. PMID: 11464429
How many patients will benefit from a new therapy for chronic systolic heart failure, and what difference does it make?
Borer JS. Borer JS. JACC Heart Fail. 2015 Mar;3(3):231-3. doi: 10.1016/j.jchf.2014.12.007. Epub 2015 Jan 28. JACC Heart Fail. 2015. PMID: 25650367 No abstract available.
[Beta blocking drugs were introduced into clinical practice 15 years ago: myths and reality].
Cocco G, Strozzi C. Cocco G, et al. Clin Ter. 1977 Jan 15;80(1):67-89. Clin Ter. 1977. PMID: 16720 Italian. No abstract available.
Eight underused prescriptions.
Kerr CP. Kerr CP. Am Fam Physician. 1994 Nov 15;50(7):1497-504. Am Fam Physician. 1994. PMID: 7976985 Review.
Mechanisms of action and the clinical pharmacology of beta-adrenergic blocking drugs.
Lowenthal DT, Saris SD, Packer J, Haratz A, Conry K. Lowenthal DT, et al. Am J Med. 1984 Oct 5;77(4A):119-27. doi: 10.1016/s0002-9343(84)80047-9. Am J Med. 1984. PMID: 6148890 Review.

See all similar articles

Cited by

Beta-blockers use in patients with chronic obstructive pulmonary disease and concomitant cardiovascular conditions.
Albouaini K, Andron M, Alahmar A, Egred M. Albouaini K, et al. Int J Chron Obstruct Pulmon Dis. 2007;2(4):535-40. Int J Chron Obstruct Pulmon Dis. 2007. PMID: 18268926 Free PMC article. Review.
Cardioselective beta-blockers for chronic obstructive pulmonary disease.
Salpeter S, Ormiston T, Salpeter E. Salpeter S, et al. Cochrane Database Syst Rev. 2005 Oct 19;2005(4):CD003566. doi: 10.1002/14651858.CD003566.pub2. Cochrane Database Syst Rev. 2005. PMID: 16235327 Free PMC article.
Cardioselective beta-blocker use in patients with reversible airway disease.
Salpeter S, Ormiston T, Salpeter E. Salpeter S, et al. Cochrane Database Syst Rev. 2001;2002(2):CD002992. doi: 10.1002/14651858.CD002992. Cochrane Database Syst Rev. 2001. Update in: Cochrane Database Syst Rev. 2002;(1):CD002992. doi: 10.1002/14651858.CD002992. PMID: 11406056 Free PMC article. Updated.
Under-utilisation of beta-blockers after acute myocardial infarction. Pharmacoeconomic implications.
Bradford WD, Chen J, Krumholz HM. Bradford WD, et al. Pharmacoeconomics. 1999 Mar;15(3):257-68. doi: 10.2165/00019053-199915030-00005. Pharmacoeconomics. 1999. PMID: 10537433 Review.
The importance of randomized clinical trials and evidence-based medicine: a clinician's perspective.
Kennedy HL. Kennedy HL. Clin Cardiol. 1999 Jan;22(1):6-12. doi: 10.1002/clc.4960220106. Clin Cardiol. 1999. PMID: 9929747 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science